Fulcrum Therapeutics, Inc.

FULC

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001680581

SEC filings (opens in a new tab)

In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Fulcrum Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of FULC: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	121	1	130	+10
Shares	64.8M	4.80M	54.9M	−5.10M (−8.5%)
Value	$402.0M	$29.8M	$196.4M	−$175.9M (−47.2%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (44)

Institutions that held Fulcrum Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to FULC in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	5,706,527	$20.4M	0.00%
TCG Crossover Management, LLC	5,250,000	$18.7M	1.59%
Nantahala Capital Management, LLC	4,777,912	$17.1M	1.44%
Braidwell LP	1,069,158	$3.82M	0.11%
Shay Capital LLC	289,237	$1.03M	0.30%
Sherbrooke Park Advisers LLC	227,225	$811.2K	0.19%
Jacobs Levy Equity Management, Inc	202,030	$721.2K	0.00%
Acadian Asset Management LLC	188,961	$674.0K	0.00%
BIT Capital GmbH	146,238	$522.1K	0.05%
Connor, Clark & Lunn Investment Management Ltd.	132,784	$474.0K	0.00%
Matisse Capital	106,717	$381.0K	0.19%
AQR Capital Management LLC	98,476	$351.6K	0.00%
Panagora Asset Management Inc	97,891	$349.5K	0.00%
Graham Capital Management, L.P.	91,216	$325.6K	0.01%
STRS Ohio	91,200	$325.6K	0.00%
Nebula Research & Development LLC	81,735	$291.8K	0.03%
Centiva Capital, LP	76,577	$273.4K	0.01%
Ikarian Capital, LLC	75,000	$267.8K	0.08%
Y-Intercept (Hong Kong) Ltd	71,103	$253.8K	0.02%
HSBC Holdings PLC	49,015	$178.4K	0.00%
Man Group plc	48,324	$172.5K	0.00%
Winton Group Ltd	44,201	$157.8K	0.01%
Verition Fund Management LLC	37,643	$134.4K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	34,081	$121.7K	0.00%
Rafferty Asset Management, LLC	32,368	$115.6K	0.00%
Federated Hermes, Inc.	25,401	$90.7K	0.00%
Mackenzie Financial Corp	23,028	$82.2K	0.00%
Prudential Financial Inc	22,675	$81.0K	0.00%
Boothbay Fund Management, LLC	21,937	$78.3K	0.00%
J. Goldman & Co LP	20,250	$72.3K	0.00%
AJOVista, LLC	18,349	$65.5K	0.28%
Intech Investment Management LLC	17,442	$62.3K	0.00%
Walleye Capital LLC	16,554	$59.1K	0.00%
ProShare Advisors LLC	15,410	$55.0K	0.00%
Perritt Capital Management Inc	5,000	$17.9K	0.01%
IFP Advisors, Inc	901	$3.21K	0.00%
GAMMA Investing LLC	198	$707	0.00%
Signaturefd, LLC	162	$578	0.00%
Sterling Capital Management LLC	140	$500	0.00%
Advisor Group Holdings, Inc.	95	$339	0.00%
Lindbrook Capital, LLC	74	$264	0.00%
Russell Investments Group, Ltd.	47	$168	0.00%
GWM Advisors LLC	3	$12	0.00%
CWM, LLC	5	$0	0.00%

Sold out (34)

Institutions that held Fulcrum Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of FULC in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
RTW Investments, LP	5,845,956	$36.2M
Cowen and Company, LLC	2,964,127	$18.4M
MPM Oncology Impact Management LP	1,444,851	$8.96M
Jefferies Financial Group Inc.	1,433,316	$8.89M
Vestal Point Capital, LP	1,160,000	$7.19M
Propel Bio Management, LLC	750,000	$4.65M
Rock Springs Capital Management LP	727,673	$4.51M
StemPoint Capital LP	696,464	$4.32M
Qube Research & Technologies Ltd	553,307	$3.43M
Silverarc Capital Management, LLC	398,436	$2.47M
Marshall Wace, LLP	333,161	$2.07M
Exome Asset Management LLC	302,700	$1.88M
Opaleye Management Inc.	285,000	$1.77M
Standard Life Aberdeen plc	256,888	$1.59M
Alyeska Investment Group, L.P.	202,148	$1.25M
Eversept Partners, LP	152,965	$948.4K
ExodusPoint Capital Management, LP	150,505	$933.0K
Jump Financial, LLC	94,181	$583.9K
Susquehanna Portfolio Strategies, LLC	81,217	$503.5K
Trexquant Investment LP	70,506	$437.1K
Alpine Global Management, LLC	59,983	$371.9K
Bank of Montreal	32,282	$204.3K
Semanteon Capital Management, LP	26,658	$165.3K
Brandywine Managers, LLC	26,127	$162.0K
Los Angeles Capital Management LLC	21,038	$130.4K
Aigen Investment Management, LP	19,311	$119.7K
Caxton Associates LP	18,875	$117.0K
Aquatic Capital Management LLC	17,300	$107.3K
Quantbot Technologies LP	14,029	$87.0K
Renaissance Technologies LLC	13,257	$82.2K
Marathon Trading Investment Management LLC	10,800	$67.0K
Landscape Capital Management, L.L.C.	10,489	$65.0K
Belvedere Trading LLC	3,988	$24.7K
BFSG, LLC	2,510	$15.6K

Not filed for Q3 2024 yet (1)

Institutions that held Fulcrum Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding FULC in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	4,798,522	$29.8M